These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26897425)

  • 1. Pharmacotherapy Considerations for the Management of Advanced Cardiac Life Support.
    Beavers CJ; Pandya KA
    Nurs Clin North Am; 2016 Mar; 51(1):69-82. PubMed ID: 26897425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced cardiovascular life support Guidelines 2000: pharmacological changes to the treatment of ventricular fibrillation/pulseless ventricular tachycardia.
    Shuster M; Tang A
    Can J Cardiol; 2001 Oct; 17(10):1022-5. PubMed ID: 11694892
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary ventricular fibrillation or pulseless ventricular tachycardia during cardiac arrest and epinephrine dosing.
    Straznitskas AD; Wong S; Kupchik N; Carlbom D
    Am J Crit Care; 2015 May; 24(3):e22-7. PubMed ID: 25934728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacologic review of cardiac arrest.
    Wagner BJ; Yunker NS
    Plast Surg Nurs; 2014; 34(3):133-8; quiz 139-40. PubMed ID: 25188852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy considerations in advanced cardiac life support.
    Dager WE; Sanoski CA; Wiggins BS; Tisdale JE
    Pharmacotherapy; 2006 Dec; 26(12):1703-29. PubMed ID: 17125434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical care providers' perceptions of the use of vasopressin in cardiac arrest.
    Heath J; Hanson D; Long R; Crowell NA
    Am J Crit Care; 2005 Nov; 14(6):481-92. PubMed ID: 16249586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review.
    de Oliveira FC; Feitosa-Filho GS; Ritt LE
    Resuscitation; 2012 Jun; 83(6):674-83. PubMed ID: 22306254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin for cardiac arrest: a systematic review and meta-analysis.
    Aung K; Htay T
    Arch Intern Med; 2005 Jan; 165(1):17-24. PubMed ID: 15642869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Panchal AR; Berg KM; Kudenchuk PJ; Del Rios M; Hirsch KG; Link MS; Kurz MC; Chan PS; Cabañas JG; Morley PT; Hazinski MF; Donnino MW
    Circulation; 2018 Dec; 138(23):e740-e749. PubMed ID: 30571262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone administration for refractory ventricular fibrillation or pulseless ventricular tachycardia.
    Rosini JM; Zizza L
    Nursing; 2016 Oct; 46(10):61-2. PubMed ID: 27654444
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of ventricular fibrillation or unstable ventricular tachycardia in patients with congenital long-QT syndrome: a suggested modification to ACLS guidelines.
    Homme JH; White RD; Ackerman MJ
    Resuscitation; 2003 Oct; 59(1):111-5. PubMed ID: 14580741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on advanced life support and resuscitation techniques.
    Hong MF; Dorian P
    Curr Opin Cardiol; 2005 Jan; 20(1):1-6. PubMed ID: 15596952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic management of cardiac emergencies.
    Fugate JH
    J Infus Nurs; 2006; 29(3):147-50. PubMed ID: 16878856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of amiodarone in the management of patients with cardiac arrest.
    Franks AM; Watterson KS
    J Ark Med Soc; 2000 Dec; 97(6):196-9. PubMed ID: 12876823
    [No Abstract]   [Full Text] [Related]  

  • 15. Update: 2015 AHA BLS and ACLS guidelines.
    Craig-Brangan KJ; Day MP
    Nursing; 2016 Feb; 46(2):40-5; quiz 45-6. PubMed ID: 26716679
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolving role of vasopressin in the treatment of cardiac arrest.
    Miano TA; Crouch MA
    Pharmacotherapy; 2006 Jun; 26(6):828-39. PubMed ID: 16716136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation.
    Wenzel V; Krismer AC; Arntz HR; Sitter H; Stadlbauer KH; Lindner KH;
    N Engl J Med; 2004 Jan; 350(2):105-13. PubMed ID: 14711909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-fidelity simulation mannequin to introduce pharmacy students to advanced cardiovascular life support.
    Mieure KD; Vincent WR; Cox MR; Jones MD
    Am J Pharm Educ; 2010 Mar; 74(2):22. PubMed ID: 20414435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for a pulseless cardiac arrest.
    Hays AJ; Corso Y
    AACN Adv Crit Care; 2007; 18(4):337-43; quiz 404-5. PubMed ID: 17978605
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasopressin and epinephrine for cardiac arrest.
    Padosch SA; Martin E; Böttiger BW
    Lancet; 2001 Dec; 358(9298):2082; author reply 2081. PubMed ID: 11755644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.